Vanda Pharmaceuticals’ expansion into the booming GLP-1 market has cleared a midphase test. | Vanda Pharmaceuticals’ ...

JSR Life Sciences is parting ways with its CRO business Crown Bioscience, selling the unit to a Chinese clinical lab service ...

Roche has reported another phase 3 win for its oral selective estrogen receptor degrader (SERD). Success at a planned interim ...

Cytokinetics may be counting down the days until the FDA decides whether to approve its cardiovascular drug aficamten. | ...

The investment bank Jefferies had been running its healthcare conference in London for 14 years as a reasonably intimate ...

Cornerstone Robotics secured about $200 million in its second round of financing this year, which the Hong Kong-based company ...

Medtronic posted a slate of strong quarterly financial results this morning, with its cardiovascular device portfolio pushing ...

Johnson & Johnson is paying $3.05 billion to acquire Halda Therapeutics, obtaining a novel cell death platform while ...

Genmab has shed another antibody-drug conjugate from its April 2024 acquisition of ProfoundBio. | Genmab has shed another ...

On its face, Biogen’s May 2024 acquisition of Human Immunology Biosciences (HI-Bio) | On its face, there wasn’t much notable ...

Through a collaboration with Edwards Lifesciences, Philips is rolling out new artificial intelligence tools designed to ...

The second Trump administration has been defined by widespread cuts to federal spending, including at the National Institutes ...